Literature DB >> 17976220

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

B Gustorff1, T Dorner, R Likar, W Grisold, K Lawrence, F Schwarz, A Rieder.   

Abstract

BACKGROUND: Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%.
METHODS: A representative survey (n=7707) was carried out. Patients with NeP were identified using previously validated criteria and subsequently asked to complete a questionnaire on QOL and detailed pain characteristics.
RESULTS: The prevalence of NeP was 3.3% (n=260). A higher prevalence was found in 41-50-year-olds (26%) and 51-60 year olds (24%). Pain was long lasting (>1 year: 66%; >5 years: 41%) and severe at onset (mean 6.8; numerical rating scale) as well as later (mean 4.7; 20% 8 or higher). Strong or predominant restriction of daily activities was reported in 65%, strong or predominant sleep disturbances in 60%, feelings of depression in 34% and anxiety in 25%.
CONCLUSION: For the first time, data on the prevalence of NeP in Austria are available. Pain patterns in those affected are characteristic and impact on QOL as well as pain intensity are severe.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976220     DOI: 10.1111/j.1399-6576.2007.01486.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  87 in total

Review 1.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 2.  Preventive aspects regarding back pain.

Authors:  Thomas E Dorner; Richard Crevenna
Journal:  Wien Med Wochenschr       Date:  2015-12-22

Review 3.  Topical capsaicin (high concentration) for chronic neuropathic pain in adults.

Authors:  Sheena Derry; Andrew Sc Rice; Peter Cole; Toni Tan; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-01-13

Review 4.  Zonisamide for neuropathic pain in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Michael P T Lunn
Journal:  Cochrane Database Syst Rev       Date:  2015-01-22

Review 5.  Clonazepam for neuropathic pain and fibromyalgia in adults.

Authors:  Ruth Corrigan; Sheena Derry; Philip J Wiffen; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 6.  Phenytoin for neuropathic pain and fibromyalgia in adults.

Authors:  Fraser Birse; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 7.  Tramadol for neuropathic pain in adults.

Authors:  Rudolf Martin Duehmke; Sheena Derry; Philip J Wiffen; Rae F Bell; Dominic Aldington; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-06-15

Review 8.  To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.

Authors:  Norman C Peterson; Elizabeth A Nunamaker; Patricia V Turner
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

Review 9.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

Review 10.  Gabapentin for chronic neuropathic pain and fibromyalgia in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Thomas Toelle; Andrew S C Rice
Journal:  Cochrane Database Syst Rev       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.